Cargando…
Structural insight into the inactivation of Mycobacterium tuberculosis non-classical transpeptidase Ldt(Mt2) by biapenem and tebipenem
BACKGROUND: The carbapenem subclass of β-lactams is among the most potent antibiotics available today. Emerging evidence shows that, unlike other subclasses of β-lactams, carbapenems bind to and inhibit non-classical transpeptidases (L,D-transpeptidases) that generate 3 → 3 linkages in bacterial pep...
Autores principales: | Bianchet, Mario A., Pan, Ying H., Basta, Leighanne A. Brammer, Saavedra, Harry, Lloyd, Evan P., Kumar, Pankaj, Mattoo, Rohini, Townsend, Craig A., Lamichhane, Gyanu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445500/ https://www.ncbi.nlm.nih.gov/pubmed/28545389 http://dx.doi.org/10.1186/s12858-017-0082-4 |
Ejemplares similares
-
Ldt(Mav2), a nonclassical transpeptidase and susceptibility of Mycobacterium avium to carbapenems
por: Mattoo, Rohini, et al.
Publicado: (2017) -
The Mycobacterium tuberculosis gene, ldt(Mt2), encodes a non-classical transpeptidase required for virulence and resistance to amoxicillin
por: Gupta, Radhika, et al.
Publicado: (2010) -
Non-classical transpeptidases yield insight into new antibacterials
por: Kumar, Pankaj, et al.
Publicado: (2016) -
Structure of Ldt(Mt2), an l,d-transpeptidase from Mycobacterium tuberculosis
por: Böth, Dominic, et al.
Publicado: (2013) -
Targeting the Mycobacterium tuberculosis transpeptidase Ldt(Mt2) with cysteine-reactive inhibitors including ebselen
por: de Munnik, Mariska, et al.
Publicado: (2019)